[ad_1]
Bill Gates, the founder of Microsoft and an entrepreneur who also provides financial support for vaccines such as AstraZeneca, Johnson & Johnson and Novavax, again raised his striking statements about vaccines.
Making a statement when news broke that mutations in the UK, South Africa and Brazil made the vaccines less effective, Gates said that the Kovid-19 vaccines, which are currently given in two doses, might need to be increased to three doses in the next period. .
Bill Gates, who provides financial support for the AstraZeneca, Johnson & Johnson and Novavax vaccines through the Bill and Melinda Gates Foundation, which he founded with his wife Melinda Gates, has warned that existing vaccines may be inappropriate for Covid-19 mutations. , another type of which is emerging every day.
Gates stressed that research that current vaccines are less effective against mutations, especially in South Africa and Brazil, may require a third dose of the Kovid-19 vaccine in the next period.
class = “cf”>
Gates, who was invited to the US CBS evening newscast and answered questions from news anchor Norah O’Donnell, stated that there are three questions about vaccines facing the world. These are the questions, according to Gates, if we need a super potent version of the current vaccine, a third dose of the same vaccines, or a new, completely modified vaccine.
Bill Gates said that all 5 vaccines produced or used in the US have already been boosted / switched against mutations and will be adjusted accordingly, in which case people who have two doses of vaccine can be re-vaccinated with a third dose.
Gates added that protecting the population from a vaccine that could be effective against all variants that affect the US and fighting the mutation in the US is the top priority for now.
class = “cf”>
THE OFFICIAL AUTHORITIES SUPPORT THE SUGGESTION
On the other hand, former US Food and Drug Administration chief Dr. Scott Gottlieb also recently told CBS that he believes the vaccines currently being administered in the US provide “reasonable protection.” against new mutations. However, Gottlieb explained that if vaccines are less effective against new strains, booster shots may be needed in the fall.
